Figure S1 a) Biosynthetic scheme showing the formation of shunt products SEK4 and SEK4b. The former incorporates the correct first ring cyclization while the latter represents an aberrantly cyclized product. b) 10% SDS PAGE analysis showing purification of KS  /KS  following nickel chelation and anion exchange chromatography. c) HPLC trace of the extract of the minimal act-PKS assay.
Figure S2
DLS autocorrelation data for coacervate droplets prepared from 2 mM PDDA/ATP at a phosphate buffer concentration of 25 mM after mixing (blue) and after 2 hours (red). In both cases, the data correspond to the presence of stable droplets greater than 10 μm in size. Autocorrelation profiles for samples run in buffer concentrations of 50 (green) and 75 mM (black) are also shown; the curves indicate only the presence of nanoscale clusters (85 and 50 nm, respectively). . Studies with the minimal PKS assay were not undertaken using the nanoscale clusters: this will be subject of future investigations. Purification of KS  /KS  and ACP: S. coelicolor act-PKS ACP was purified and analysed using SDS PAGE using standard protocols. The plasmid was transformed into E. coli strain BL21(DE3) for isopropyl β-D-thiogalactopyranoside (IPTG)-induced expression. 1,2 Once the A 600 nm of the incubating culture (37 °C) reached a value of 0.6, induction was initiated by the addition of IPTG to a final concentration of 1mM. The C17S mutant of act ACP was used to reduce intermolecular dimerization as well as internal disulfide formation between C17 and the terminal thiol of the 4 ' -phosphopantetheine (4 ' -PP) prosthetic group. 3 Purified act ACP was desalted into distilled water using a HiPrep TM Sephadex G-25 HR 26/10 column and lyophilized. Activity of the act ACP was initially followed by self-malonylation. 4, 5 For this, actholo-ACP (50 M) was incubated with malonyl-CoA (50 M) for 30 minutes at 30 °C in potassium phosphate buffer (100 mM, pH 7.3, 10 % v/v glycerol, 100 L total assay volume). Reactions were quenched by addition of C4 resin and prepared for mass spectrometric (MS)
analysis using the methods of Winston et al. 6 MS analysis was performed using an Applied Biosystems QSTAR ® XL hybrid quadrupole time-of-flight instrument. S. coelicolor KS  KS  was purified following methods first described by Matharu et al. 7 Pooled protein fractions were desalted into 100 mM potassium phosphate buffer (pH 7.3, containing 2 mM DTT, 2 mM EDTA, 10 % v/v glycerol), aliquoted, flash frozen in liquid nitrogen and stored at -80 °C.
In vitro minimal PKS assays contained act PKS holo-ACP, which had been previously incubated with TCEP (2 mM, 60 minutes) to ensure monomerisation of the carrier protein.
Minimal PKS assay: KS  /KS  (1 M) was incubated (10 minutes, 30 °C) with ACP (50 M) in potassium phosphate buffer (25 mM, pH 7.3) containing glycerol (10% v/v), TCEP (2 mM) and EDTA (2 mM) in a final volume of 100 L allowing the formation of the active complex. Polyketide production was initiated by the addition of malonyl CoA (1 mM) and assays incubated for a further 2 hours at 30°C with shaking. Following incubation, assays were quenched by addition of solid NaH 2 PO 4 (100 mg) and then extracted with ethyl acetate (3 x 300 L). Following evaporation under nitrogen the residue was dissolved in HPLC grade methanol (100 L). Extracts were analysed by reverse phase HPLC (Luna 5  C18 (2) Products SEK4 and SEK4b were quantified using calibration curves of pure standards. For minimal PKS assays incorporating coacervate components, solutions of 50 mM ATP and 50 mM PDDA were added individually and then in combination (50 mM ATP + 50 mM PDDA) to the assay to give final concentrations of both components of 2 mM, maintaining the total volume at 100 L in each case. The minimal assay was also repeated across a range of salt concentrations (5, 10, 20, 50, 80, 100, 150 and 200 mM NaCl) both in the presence and absence of the coacervate, again keeping the final assay volume at 100 L.
Partitioning experiments: KS  /KS  (1.8 mg/mL, 100 L,) was added to a solution containing ATP (50 mM, 700 L) and PDDA (50 mM, 700 L) and equilibrated for 5 minutes. This solution was then centrifuged (12,480 x g, 20°C, 5 minutes) in order to separate the aqueous and coacervate phases. The concentration of KS  /KS  in both phases was determined using the Bradford protein assay, and the partition constant given by the ([KS  /KS   coacervate KS  /KS   supernatant ) concentration ratio. To analyse the coacervate phase, 10 L was added to 1 M NaCl (190 L) to disassemble the PDDA/ATP complex. Determination of the ACP partitioning constant was undertaken using essentially the same method with ACP (2 mg/mL, 100l) replacing the KS  /KS  complex.
